National Cancer Institute

Largest Yet Mesothelioma Study Shows Survival Benefit with New Drug
20 May 02 | Researchers with the largest Phase III trial to date for mesothelioma, an aggressive cancer affecting the lining of the lung, reported results showing that patients on a new chemotherapy drug regimen live longer and have less pain.

NCI Announces CanCORS Grants for 2001
19 Oct 01 | The National Cancer Institute (NCI) has awarded $5.1 million in first-year funding to seven grantees for research on measuring the quality of cancer care in the United States. This five-year project, titled "Cancer Care Outcomes Research and ...

Obesity and Cancer
25 Sep 01 | Several cancers are associated with obesity: those of the breast, endometrium, colon, kidney, esophagus, stomach, and gallbladder. Some studies have also reported links between obesity and cancers of the prostate, ovaries, and pancreas.

NCI Director Richard Klausner Will Leave NIH to Head the Case Institute
11 Sep 01 | Richard D. Klausner, M.D., announced today that he plans to step down from his post as director of the National Cancer Institute (NCI) at the National Institutes of Health (NIH) on Sept. 30. "As NCI director, Rick summoned a unique blend of ...

First Major Trial of Digital Mammography Launched
04 Sep 01 | The National Cancer Institute (NCI) and the American College of Radiology Imaging Network (ACRIN) are launching the first large, multicenter study to compare digital mammography to standard mammography for the detection of breast cancer. The ...

Questions and Answers About Hormone Replacement Therapy
23 Aug 01 | Hormone replacement therapy (HRT) is treatment with hormones, either estrogen alone or in combination with progestin (preparations that have effects similar to that of progesterone), to replenish the natural hormones that decrease at menopause. ...

Questions and Answers: SELECT (Selenium and Vitamin E Cancer Prevention Trial)
10 Aug 01 | SELECT stands for the Selenium and Vitamin E Cancer Prevention Trial, which is a clinical trial to see if one or both of these dietary supplements prevent prostate cancer in men. After skin cancer, prostate cancer is the most common type of ...

PLCO Cancer Screening Trial Completes Recruitment
26 Jul 01 | The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, sponsored by the National Cancer Institute (NCI), reached a significant milestone last month with the enrollment of its final participant. For prostate cancer, PLCO centers...

Scientists Report Complete Remissions in Early Leukemia Trial
25 Jul 01 | Scientists report today in the New England Journal of Medicine* that 11 of 13 patients with hairy cell leukemia, a cancer of the immune system, had complete remissions after receiving adequate treatment with the recombinant immunotoxin BL22. A ...

Israel-NCI Study* of the Use of Oral Contraceptives and Risk of Ovarian Cancer in Women with Alterations in BRCA1 or BRCA2 Genes
25 Jul 01 | The purpose of the current study was to evaluate whether the use of oral contraceptives reduces the risk of ovarian cancer in women with specific alterations in BRCA1 and BRCA2 genes. The researchers found that for women with alterations in BRCA1...

Largest-Ever Prostate Cancer Prevention Trial Opens: 32,000 Men Sought to Test Vitamin E and Selenium
24 Jul 01 | The Selenium and Vitamin E Cancer Prevention Trial, or SELECT, will determine if these two dietary supplements can protect against prostate cancer, the most common form of cancer, after skin cancer, in men. "Previous research with vitamin E and ...

New Joint Program Announced by FDA and NCI Holds Promise for Cancer
20 Jul 01 | The Food and Drug Administration (FDA) and the National Cancer Institute (NCI) announced today a new joint research and clinical program that holds great promise for developing better and more targeted treatments for cancer. The new program, ...

Scientists Find Similar Survival Rates for Eye Cancer Therapies: Research Also Increases Nationwide Availability of Treatments
12 Jul 01 | Researchers have found that the survival rates for two alternative treatments for primary eye cancer - radiation therapy and removal of the eye - are about the same. Also, as a consequence of this research, the capability of doctors nationwide to...

Nasopharyngeal Radium Irradiation
03 Jul 01 | Between the 1920s and 1960s, nasopharyngeal radium irradiation (NRI) was considered good medical practice and effective treatment for a number of medical problems of the head and neck. In addition to two case reports (Katz & Preston-Martin, 1984;...

Questions and Answers about H. Pylori and Pancreatic Cancer
19 Jun 01 | If there is indeed a connection between H. Pylori and pancreatic cancer, the proportion of people with H. Pylori infection who develop pancreatic cancer would be small. As smoking is the most consistent risk factor for pancreatic cancer, a larger...

Questions and Answers: Annual Report to the Nation on the Status of Cancer, 1973-1998; Feature Focuses on Cancers with Recent Increasing Trends
05 Jun 01 | This report provides an update on the trends in cancer incidence (new cases reported) and death rates in the United States. The North American Association of Central Cancer Registries (NAACCR); the Centers for Disease Control and Prevention (CDC...

Annual Report Shows Overall Decline in U.S. Cancer Incidence and Death Rates;Feature Focuses on Cancers with Recent Increasing Trends
05 Jun 01 | The report is by the North American Association of Central Cancer Registries (NAACCR); the Centers for Disease Control and Prevention (CDC), including the National Center for Health Statistics (NCHS); the American Cancer Society (ACS); and the ...

Resource Information for Cancer and the Environment
31 May 01 | 1. What is the National Cancer Institute's role in protecting the public from cancer-causing substances in the environment? The National Cancer Institute (NCI) is the largest government cancer research organization in the country.

Temporary Suspension of Colorectal Cancer Trials Involving Irinotecan and the Saltz Regimen Announced
23 May 01 | In April 2001 two NCI-funded clinical trials of colorectal cancer were temporarily suspended because some patient deaths appeared to be related to treatment. The two phase III trials, being carried out by two separate national cooperative groups ...

Simian Virus 40 and Human Cancer
22 May 01 | In spite of these negative findings, there is some evidence to suggest that SV40, unrelated to polio vaccine, may be associated with human cancer. In order to resolve why some laboratories detect traces of SV40 in mesothelioma while others do not...

« prev  1  2  3  4  5  6  7  8  9  10  11   next »

 

Home » Medical Research » National Cancer Institute » News